BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33109220)

  • 1. NF-κB maintains the stemness of colon cancer cells by downregulating miR-195-5p/497-5p and upregulating MCM2.
    Wang L; Guo J; Zhou J; Wang D; Kang X; Zhou L
    J Exp Clin Cancer Res; 2020 Oct; 39(1):225. PubMed ID: 33109220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.
    Huang Y; Luo F
    IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
    Wang C; Yin W; Liu H
    J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of MicroRNA-302c on Stemness of Colon Cancer Stem Cells via the CARF/Wnt/β-Catenin Axis.
    Zhang Y; Meng H; Guo K
    Dig Dis Sci; 2021 Jun; 66(6):1906-1915. PubMed ID: 32617772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2.
    Hongdan L; Feng L
    Biochem Biophys Res Commun; 2018 Feb; 496(2):302-308. PubMed ID: 29307822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-139-5p reverses stemness maintenance and metastasis of colon cancer stem-like cells by targeting E2-2.
    Ma X; Liu J; Li J; Li Y; Le VM; Li S; Liang X; Liu L; Liu J
    J Cell Physiol; 2019 Dec; 234(12):22703-22718. PubMed ID: 31120140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1.
    Zhan P; Shu X; Chen M; Sun L; Yu L; Liu J; Sun L; Yang Z; Ran Y
    Life Sci; 2021 Jul; 276():119405. PubMed ID: 33798550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis.
    Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G; Wang K
    J Cell Physiol; 2019 Nov; 234(11):20816-20828. PubMed ID: 31012108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in
    Inoue A; Mizushima T; Wu X; Okuzaki D; Kambara N; Ishikawa S; Wang J; Qian Y; Hirose H; Yokoyama Y; Ikeshima R; Hiraki M; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
    Mol Cancer Ther; 2018 May; 17(5):977-987. PubMed ID: 29545333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades.
    Zhao G; Yin Y; Zhao B
    J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
    Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
    Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-200c/FUT4 axis prevents the proliferation of colon cancer cells by downregulating the Wnt/β-catenin pathway.
    Cong J; Gong J; Yang C; Xia Z; Zhang H
    BMC Cancer; 2021 Jan; 21(1):2. PubMed ID: 33397320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer.
    Yang H; Lin J; Jiang J; Ji J; Wang C; Zhang J
    Cell Cycle; 2020 Nov; 19(21):2939-2954. PubMed ID: 33044899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4.
    Gen Y; Muramatsu T; Inoue J; Inazawa J
    Cancer Res; 2021 Oct; 81(20):5190-5201. PubMed ID: 34353856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
    Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
    Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
    Jia Y; Ding X; Zhou L; Zhang L; Yang X
    Oncogene; 2021 Jan; 40(2):246-261. PubMed ID: 33122828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
    Yu X; Mi L; Dong J; Zou J
    BMC Cancer; 2017 Nov; 17(1):716. PubMed ID: 29110645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.